Mark Dayan assesses the impact of Brexit on the health service, looking at the effect on funding, the workforce and medicine supplies.

Three years ago, on 31 January 2020, the British flags that had flown outside European Union buildings for over 40 years were lowered. The then prime minister Boris Johnson had “got Brexit done.” Except he hadn’t.

The Nuffield Trust think tank has published a new report on the impact of Brexit on the UK’s health and care services. The ongoing monitoring work, funded by the Health Foundation, covers the impact on the NHS and social care workforce, medicine and medical devices supply and the economic cost, and reveals negative effects across these areas.

Jacob Rees-Mogg has published a list of nine ‘Brexit opportunities’. It’s both pitiful and dangerous.

Those on the frontline are caught between political uncertainty and a scared and sometimes angry public.

The Yellowhammer report suggests medical supplies could be disrupted by a no-deal but a fragile system means it’s more complicated than that.

The Good Law Project has today threatened to issue judicial review proceedings on Tuesday 26 February unless Government cancels powers to allow pharmacists to alter prescriptions for people with serious medical conditions in the event of medicines shortages.

Pharmacists say minor delays at ports could have knock-on effects in lean supply chain.

Patients are complaining of delays in getting access to drugs.

Pharmacists will overrule GPs to ration drugs under a no-deal Brexit, The Times has learnt. / Ministers will order them to alter prescriptions without first contacting the patient’s GP in order to mitigate any extreme shortages, according to a leaked document.